TY - JOUR
T1 - Iron uptake in quiescent and inflammation-activated astrocytes
T2 - A potentially neuroprotective control of iron burden
AU - Pelizzoni, Ilaria
AU - Zacchetti, Daniele
AU - Campanella, Alessandro
AU - Grohovaz, Fabio
AU - Codazzi, Franca
PY - 2013/8
Y1 - 2013/8
N2 - Astrocytes play a crucial role in proper iron handling within the central nervous system. This competence can be fundamental, particularly during neuroinflammation, and neurodegenerative processes, where an increase in iron content can favor oxidative stress, thereby worsening disease progression. Under these pathological conditions, astrocytes undergo a process of activation that confers them either a beneficial or a detrimental role on neuronal survival. Our work investigates the mechanisms of iron entry in cultures of quiescent and activated hippocampal astrocytes. Our data confirm that the main source of iron is the non-transferrin-bound iron (NTBI) and show the involvement of two different routes for its entry: the resident transient receptor potential (TRP) channels in quiescent astrocytes and the de novo expressed divalent metal transporter 1 (DMT1) in activated astrocytes, which accounts for a potentiation of iron entry. Overall, our data suggest that at rest, but even more after activation, astrocytes have the potential to buffer the excess of iron, thereby protecting neurons from iron overload. These findings further extend our understanding of the protective role of astrocytes under the conditions of iron-mediated oxidative stress observed in several neurodegenerative conditions. Non-transferrin-bound iron (NTBI) is the main source of iron for astrocytes. TRPC channels represent an entry pathway for Fe2+ in resting astrocytes. Activation process increases the competence of astrocytes to uptake iron. DMT1 expression accounts for potentiation of iron ingress in activated astrocytes.
AB - Astrocytes play a crucial role in proper iron handling within the central nervous system. This competence can be fundamental, particularly during neuroinflammation, and neurodegenerative processes, where an increase in iron content can favor oxidative stress, thereby worsening disease progression. Under these pathological conditions, astrocytes undergo a process of activation that confers them either a beneficial or a detrimental role on neuronal survival. Our work investigates the mechanisms of iron entry in cultures of quiescent and activated hippocampal astrocytes. Our data confirm that the main source of iron is the non-transferrin-bound iron (NTBI) and show the involvement of two different routes for its entry: the resident transient receptor potential (TRP) channels in quiescent astrocytes and the de novo expressed divalent metal transporter 1 (DMT1) in activated astrocytes, which accounts for a potentiation of iron entry. Overall, our data suggest that at rest, but even more after activation, astrocytes have the potential to buffer the excess of iron, thereby protecting neurons from iron overload. These findings further extend our understanding of the protective role of astrocytes under the conditions of iron-mediated oxidative stress observed in several neurodegenerative conditions. Non-transferrin-bound iron (NTBI) is the main source of iron for astrocytes. TRPC channels represent an entry pathway for Fe2+ in resting astrocytes. Activation process increases the competence of astrocytes to uptake iron. DMT1 expression accounts for potentiation of iron ingress in activated astrocytes.
KW - Activation process
KW - Astrocytes
KW - DMT1
KW - Neuroinflammation
KW - Non-transferrin-bound iron uptake
KW - TRP channels
UR - http://www.scopus.com/inward/record.url?scp=84877340972&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877340972&partnerID=8YFLogxK
U2 - 10.1016/j.bbadis.2013.04.007
DO - 10.1016/j.bbadis.2013.04.007
M3 - Article
C2 - 23583428
AN - SCOPUS:84877340972
SN - 0925-4439
VL - 1832
SP - 1326
EP - 1333
JO - Biochimica et Biophysica Acta - Molecular Basis of Disease
JF - Biochimica et Biophysica Acta - Molecular Basis of Disease
IS - 8
ER -